To help fill the increasing need for antibacterial cleaning supplies in response to the covid-19 pandemic, Contec, Osaka, Japan, is scaling up production of its Sporicidin brand disinfectant, most often used for mold and water damage remediation. The company has partnered with Milliken, Spartanburg, SC, to help produce mass quantities of the disinfectant.
Sporicidin disinfectant has been used for infection and contamination control by hospitals, medical and dental offices, veterinary clinics, and restoration professionals since 1978. The EPA-registered intermediate-level disinfectant cleans, deodorizes, disinfects, and provides 100% kill of pathogenic vegetative organisms—including avian influenza A virus (H1N1 and H9N2), methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci—with continuous residual activity for up to 6 months. Compatible with glass, metals, plastics, and wood, Sporicidin is alcohol-free, nonabrasive, noncorrosive, and nonstaining.
“Milliken immediately came to mind when we decided to bring on a new manufacturing partner,” says Jack McBride, chief executive officer of Contec. “Milliken is a trusted, key community player with the mass production, quality systems, and speed-to-market capabilities needed to help us provide critical cleaning solutions to healthcare facilities without delay.”
Sporicidin production at Milliken began on May 12, after a record ramp-up of only 4 weeks. In the past, arranging similar partnerships has typically required 3 to 6 months.
“Companies are adapting their core competencies to meet the global challenges brought on by covid-19,” says Halsey M. Cook, president and chief executive officer of Milliken. “Partnering with Contec was a natural fit and gave Milliken the opportunity to quickly reconfigure our manufacturing capabilities and rapidly solve problems for our customers and communities.”
For more information, visit Contec.